New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
11:57 EDTAFFXAffymetrix gets FDA approval for CytoScan Dx Assay
The U.S. FDA authorized for marketing the Affymetrix CytoScan Dx Assay, which can detect chromosomal variations that may be responsible for a child's developmental delay or intellectual disability. Based on a blood sample, the test can analyze the entire genome at one time and detect large and small chromosomal changes.
News For AFFX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AFFX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use